AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.

✈️ Comparative Airlines ReportComparative Airlines Report

UAL vs AAL vs DAL – Analisi Comparativa dei Big 3 delle Compagnie Aeree USAUAL vs AAL vs DAL – Comparative Analysis of US Big 3 Airlines

Report Date:Report Date: November 12, 2025 ⏰ Ora:Time: 5:37 PM CET WEEKLY PERFORMANCE: UAL +6.40% | AAL +4.58% | DAL +4.94%

Snapshot Comparativo – Le 3 Maggiori Compagnie Aeree USAComparative Snapshot – Top 3 US Airlines

United Airlines (UAL) – Market Leader
Strongest performer this week (+6.40%) • Market Cap $31.9B • Second-lowest P/E (9.87) • Highest EBITDA $8.5B • Revenue growth 6.23%

American Airlines (AAL) – Weakest Position
Moderate gains (+4.58%) • Market Cap $8.81B • Highest P/E (15.34) • Lowest EBITDA $5.01B • Slowest revenue growth 2.70%

Delta Air Lines (DAL) – Balanced Profile
Strong gains (+4.94%) • Market Cap $38.82B (Largest) • Highest net income $3.46B • Largest revenue $61.64B • Best dividend yield 1.14%

United Airlines (UAL) – Market Leader
Strongest performer this week (+6.40%) • Market Cap $31.9B • Second-lowest P/E (9.87) • Highest EBITDA $8.5B • Revenue growth 6.23%

American Airlines (AAL) – Weakest Position
Moderate gains (+4.58%) • Market Cap $8.81B • Highest P/E (15.34) • Lowest EBITDA $5.01B • Slowest revenue growth 2.70%

Delta Air Lines (DAL) – Balanced Profile
Strong gains (+4.94%) • Market Cap $38.82B (Largest) • Highest net income $3.46B • Largest revenue $61.64B • Best dividend yield 1.14%

Dati Prezzi Settimanali (Nov 5-12, 2025)Weekly Price Data (Nov 5-12, 2025)

UAL
United Airlines Holdings, Inc.
NASDAQ
Prezzo AttualeCurrent Price
$98.19
Apertura SettimanaWeek Open $92.28
Guadagno SettimanaleWeekly Gain +6.40%
52-Week Range52-Week Range $91.49 → $100.62
Market CapMarket Cap $31.90B
P/E RatioP/E Ratio 9.87
EPSEPS $9.58
AAL
American Airlines Group Inc.
NASDAQ
Prezzo AttualeCurrent Price
$13.35
Apertura SettimanaWeek Open $12.76
Guadagno SettimanaleWeekly Gain +4.58%
52-Week Range52-Week Range $12.75 → $14.05
Market CapMarket Cap $8.81B
P/E RatioP/E Ratio 15.34
EPSEPS $1.29
DAL
Delta Air Lines, Inc.
NYSE
Prezzo AttualeCurrent Price
$59.08
Apertura SettimanaWeek Open $56.30
Guadagno SettimanaleWeekly Gain +4.94%
52-Week Range52-Week Range $56.03 → $60.61
Market CapMarket Cap $38.82B
P/E RatioP/E Ratio 8.38
EPSEPS $5.39

Comparazione Finanziaria 2024 vs 2023Financial Comparison 2024 vs 2023

MetricaMetricUALAALDALLeaderLeader
Revenue 2024Revenue 2024$57.06B$54.21B$61.64BDAL
Revenue Growth YoYRevenue Growth YoY+6.23%+2.70%+6.19%UAL
Operating IncomeOperating Income$5.10B$3.26B$6.00BDAL
Net Income 2024Net Income 2024$3.15B$0.85B$3.46BDAL
EBITDAEBITDA$8.50B$5.01B$7.92BUAL
EPSEPS$9.58$1.29$5.39UAL

Metriche di ValutazioneValuation Metrics

MetricaMetricUALAALDALInterpretazioneInterpretation
P/E Ratio9.8715.348.38DAL with the lowest valuation in the group (lowest P/E)
Market CapMarket Cap$31.90B$8.81B$38.82BDAL largest by market cap
Dividend YieldDividend Yield0.0%0.0%1.14%DAL only dividend payer
Net Profit MarginNet Profit Margin5.52%1.57%5.61%DAL & UAL healthy margins

Classifche e AnalisiRankings & Analysis

Miglior Valutazione (P/E)Best Valuation (P/E)
1st: DAL – 8.38
2nd: UAL – 9.87
3rd: AAL – 15.34
Profittabilità (Net Income)Profitability (Net Income)
1st: DAL – $3.46B
2nd: UAL – $3.15B
3rd: AAL – $0.85B
Performance SettimanaleWeekly Performance
1st: UAL – +6.40%
2nd: DAL – +4.94%
3rd: AAL – +4.58%
Dimensione RevenueRevenue Size
1st: DAL – $61.64B
2nd: UAL – $57.06B
3rd: AAL – $54.21B
Crescita Revenue YoYRevenue Growth YoY
1st: UAL – +6.23%
2nd: DAL – +6.19%
3rd: AAL – +2.70%
EBITDA StrengthEBITDA Strength
1st: UAL – $8.50B
2nd: DAL – $7.92B
3rd: AAL – $5.01B

Prospettiva di Investimento per StockInvestment Perspective per Stock

UAL
Caso di InvestimentoInvestment Case
✅ Positivi:
• Highest EBITDA ($8.5B)
• Highest EPS ($9.58)
• Best weekly performance (+6.40%)
• Strong revenue growth (6.23%)

⚠️ Rischi:
• No dividend yield
• Higher valuation risk
✅ Positives:
• Highest EBITDA ($8.5B)
• Highest EPS ($9.58)
• Best weekly performance (+6.40%)
• Strong revenue growth (6.23%)

⚠️ Risks:
• No dividend yield
• Higher valuation risk
AAL
Caso di InvestimentoInvestment Case
⚠️ Problemi:
• Lowest net income ($0.85B)
• Highest P/E ratio (15.34)
• Slowest revenue growth (2.70%)
• Smallest market cap ($8.81B)

✅ Opportunità:
• Turnaround potential
• Underdog positioning
⚠️ Issues:
• Lowest net income ($0.85B)
• Highest P/E ratio (15.34)
• Slowest revenue growth (2.70%)
• Smallest market cap ($8.81B)

✅ Opportunity:
• Turnaround potential
• Underdog positioning
DAL
Caso di InvestimentoInvestment Case
✅ Punti Forti:
• Lowest P/E in the group (8.38)
• Highest profitability ($3.46B)
• Only dividend payer (1.14%)
• Largest market cap ($38.82B)

⚠️ Considerazioni:
• Premium valuation vs peers
• Limited upside potential
✅ Strengths:
• Lowest P/E in the group (8.38)
• Highest profitability ($3.46B)
• Only dividend payer (1.14%)
• Largest market cap ($38.82B)

⚠️ Considerations:
• Premium valuation vs peers
• Limited upside potential

Considerazioni finaliFinal Takeaways

✈️ Confronto finale per profilo di rischio✈️ Final Comparison by Risk Profile

Profilo dividendo + stabilità:
DAL – only dividend payer in the group (1.14%), lowest P/E (8.38), largest market cap

Profilo crescita + momentum:
UAL – highest EBITDA ($8.5B), highest EPS ($9.58), best weekly performance (+6.40%)

Profilo value/turnaround:
DAL – solid fundamentals and the lowest P/E in the group (8.38)
AAL – speculative turnaround profile, with the highest P/E (15.34) and the weakest fundamentals

Comparative summary: on the metrics reviewed (valuation, profitability, dividend), DAL shows the most balanced profile, followed by UAL and then AAL. This is a descriptive comparison, not a recommendation to buy or sell.

Dividend + stability profile:
DAL – only dividend payer in the group (1.14%), lowest P/E (8.38), largest market cap

Growth + momentum profile:
UAL – highest EBITDA ($8.5B), highest EPS ($9.58), best weekly performance (+6.40%)

Value/turnaround profile:
DAL – solid fundamentals and the lowest P/E in the group (8.38)
AAL – speculative turnaround profile, with the highest P/E (15.34) and the weakest fundamentals

Comparative summary: on the metrics reviewed (valuation, profitability, dividend), DAL shows the most balanced profile, followed by UAL and then AAL. This is a descriptive comparison, not a recommendation to buy or sell.

Nota Conclusiva:Final Note: UAL vs AAL vs DAL – Tutte e tre le compagnie aeree hanno performance settimanale positiva. DAL offre il miglior equilibrio di valutazione + profittabilità + dividend yield. UAL offre il miglior growth story. AAL rimane la more risky tra le tre. Industria aeree recovery positiva post-2023. Settore airlines sta mostrando forte momentum al Q4 2025.UAL vs AAL vs DAL – All three airlines showing positive weekly performance. DAL offers best balance of valuation + profitability + dividend yield. UAL offers best growth story. AAL remains riskiest of the three. Airlines industry showing positive recovery post-2023. Airlines sector showing strong momentum into Q4 2025.

Report comparativo Merlintrader | Airline Industry Comparative Analysis | 12 novembre 2025Merlintrader Comparative Report | Airline Industry Comparative Analysis | November 12, 2025

© 2025 – Solo a scopo informativo ed educativo; non costituisce consulenza finanziaria né raccomandazione di acquisto o vendita. Dati confermati il 12 novembre 2025 – 5:37 PM CET.For informational and educational purposes only; not financial advice or a recommendation to buy or sell. Data confirmed November 12, 2025 – 5:37 PM CET.

Trending now

Conceptual illustration of minerals, mining, electricity infrastructure and a data center at dusk.
Minerals, Megawatts and Money: The Race From Strategic Assets to Shareholder Returns — $BE, $OKLO, $LAC, $CRML
Merlintrader Biotech Radar, October 7, 2026: $ARWR, $ARVN, $LPCN, $MAIA and $RNXT; conceptual laboratory and molecular illustration.
Biotech Radar, October 7: regulatory progress, Parkinson’s data and oncology milestones
Illustration of the liver and metabolic research, with the original Merlintrader logo and ALT, VKTX, IVA and MDGL tickers.
MASH beyond weight loss: what $ALT, $VKTX, $IVA and $MDGL actually have to prove
Illustration of red blood cells and sickled cells, with the original Merlintrader logo and AGIO, CRSP, BEAM and NVO tickers.
Sickle cell: what progress means for $AGIO, $CRSP, $BEAM and $NVO